Results 11 to 20 of about 61,069,248 (252)

IL21R (interleukin 21 receptor) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
Review on IL21R (interleukin 21 receptor), with data on DNA, on the protein encoded, and where the gene is implicated.
Ferrini, S, Fabbi, M
core   +8 more sources

Interleukin-21 in cancer immunotherapy [PDF]

open access: yesOncoImmunology, 2012
Interleukin (IL)-21, a cytokine produced by activated conventional CD4+ T lymphocytes and Natural Killer T cells, drives anti-tumor immunity in the skin and kidney. However IL-21 is also pro-inflammatory in many tissues and promotes colitis-associated colon cancer.
Stolfi, C   +3 more
openaire   +4 more sources

Differential regulation of interleukin-17 and interferon-y production in inflammatory bowel disease [PDF]

open access: yes, 2010
PhDBackground and Aims. Interleukin (IL)-17 is now known to be involved in a number of chronic inflammatory disorders. However, the mechanisms regulating its production in inflammatory bowel disease (IBD) are still unclear. Methods.
Rovedatti, Laura
core   +4 more sources

Cloning and characterization of an isoform of interleukin‐21 [PDF]

open access: yesFEBS Letters, 2007
Interleukin‐21 (IL‐21) has pleiotropic functions on the cells, which play roles in both innate and acquired immunity, such as T cells, B cells, natural killer (NK) cells and dendritic cells. In this study we identified a novel isoform of IL‐21, IL‐21iso in human and mouse. IL‐21iso might be an alternative splicing variant form and the C‐terminal region
Rahman, Mizanur   +6 more
openaire   +2 more sources

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies [PDF]

open access: yes, 2012
BACKGROUND: Persistent inflammation has been proposed to contribute to various stages in the pathogenesis of cardiovascular disease. Interleukin-6 receptor (IL6R) signalling propagates downstream inflammation cascades.
Thomas, GN   +489 more
core   +3 more sources

Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls

open access: yesDermatology Practical & Conceptual, 2021
Background: Pemphigus is a rare group of autoimmune blistering diseases with unknown etiology and unclear pathogenesis. Pemphigus vulgaris (PV) is the most common subtype, and is characterized by ulcerations or flaccid blisters on mucous membranes and on
Pegah Shahbazian   +7 more
doaj   +1 more source

Peran Reseptor IL-21 (IL-21R) sebagai Target Terapi Pada Penyakit Arteri Perifer

open access: yesScripta Score Scientific Medical Journal, 2021
Background: Peripheral Artery Disease (PAD) is caused due to the disruption of blood supply to the periphery caused by blockages in the arteries. PAD is a disease that is difficult to detect and the current therapy is still limited to pharmacological ...
Muhammad Luthfi Adnan
doaj   +1 more source

The role of interleukin-21 in HIV infection [PDF]

open access: yesCytokine & Growth Factor Reviews, 2012
Interleukin (IL)-21 is one of a group of cytokines including IL-2, IL-4, IL-7, IL-9 and IL-15 whose receptor complexes share the common γ chain (γ(c)). Secretion of IL-21 is restricted mainly to T follicular helper (TFH) CD4 T cell subset with contributions from Th17, natural killer (NK) T cells, but the effects of IL-21 are pleiotropic, owing to the ...
Suresh, Pallikkuth   +2 more
openaire   +2 more sources

Interleukin 21 Receptor Affects Adipogenesis of Human Adipose-Derived Stem/Stromal Cells

open access: yesStem Cells International, 2022
Dysfunctions in adipose tissue cells are responsible for several obesity-related metabolic diseases. Understanding the process of adipocyte formation is thus fundamental for understanding these diseases.
Bruna Cristina Falavinha   +7 more
doaj   +1 more source

Pathogenic role of interleukin-21 in psoriasis [PDF]

open access: yesCell Cycle, 2009
Psoriasis is a chronic inflammatory disease of the skin characterized by keratinocyte hyperplasia and dermal infiltration with inflammatory cells. Driving factors the epidermal hyperplasia in psoriasis are not fully understood, but there is evidence that T cell-derived cytokines can be involved. In this article, we focus on the recent data indicating a
CARUSO, ROBERTA   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy